Vigabatrin recalls
The FDA has published 2 recalls involving Vigabatrin since 2023. The latest was reported on 17 Jan 2024. InvaGen Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2023
Last 12 months0reported
Class I150% of total
Ongoing0latest 17 Jan 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 50%Class II 0 0%Class III 1 50%
Why vigabatrin is recalled
Companies
Brands
By year
All vigabatrin recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets recalledVigabatrin | InvaGen Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS III | Sabril (vigabatrin) for Oral Solution, 500 mg, 50 Packets recalledSabril | Lundbeck | Other | Nationwide |
Should you stop taking Vigabatrin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.